PLN 20.0
(4.17%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 315.68 Million PLN | 79.73% |
2022 | 175.64 Million PLN | -33.75% |
2021 | 265.14 Million PLN | -9.96% |
2020 | 294.48 Million PLN | -5.66% |
2019 | 312.14 Million PLN | 176.9% |
2018 | 112.72 Million PLN | 10.19% |
2017 | 102.29 Million PLN | 16.94% |
2016 | 87.48 Million PLN | 8.78% |
2015 | 80.42 Million PLN | 33.44% |
2014 | 60.26 Million PLN | -4.22% |
2013 | 62.92 Million PLN | -15.67% |
2012 | 74.61 Million PLN | 13.67% |
2011 | 65.64 Million PLN | 16.62% |
2010 | 56.29 Million PLN | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 354.37 Million PLN | 5.88% |
2024 Q1 | 334.69 Million PLN | 6.02% |
2023 FY | 315.68 Million PLN | 79.73% |
2023 Q4 | 315.68 Million PLN | 2.02% |
2023 Q1 | 325.03 Million PLN | 85.05% |
2023 Q2 | 322.08 Million PLN | -0.91% |
2023 Q3 | 309.42 Million PLN | -3.93% |
2022 Q1 | 280.52 Million PLN | 5.8% |
2022 FY | 175.64 Million PLN | -33.75% |
2022 Q3 | 288.85 Million PLN | 4.52% |
2022 Q4 | 175.64 Million PLN | -39.19% |
2022 Q2 | 276.35 Million PLN | -1.49% |
2021 Q4 | 265.14 Million PLN | -5.8% |
2021 FY | 265.14 Million PLN | -9.96% |
2021 Q1 | 290.08 Million PLN | -1.49% |
2021 Q2 | 283.24 Million PLN | -2.36% |
2021 Q3 | 281.48 Million PLN | -0.62% |
2020 FY | 294.48 Million PLN | -5.66% |
2020 Q4 | 294.48 Million PLN | -3.17% |
2020 Q2 | 300.86 Million PLN | -4.04% |
2020 Q1 | 313.54 Million PLN | 0.45% |
2020 Q3 | 304.13 Million PLN | 1.09% |
2019 Q4 | 312.14 Million PLN | 0.54% |
2019 Q1 | 319.01 Million PLN | 183.0% |
2019 FY | 312.14 Million PLN | 176.9% |
2019 Q3 | 310.46 Million PLN | -2.98% |
2019 Q2 | 320 Million PLN | 0.31% |
2018 Q3 | 102.46 Million PLN | 2.11% |
2018 Q2 | 100.35 Million PLN | -0.39% |
2018 FY | 112.72 Million PLN | 10.19% |
2018 Q1 | 100.75 Million PLN | -1.51% |
2018 Q4 | 112.72 Million PLN | 10.01% |
2017 Q3 | 89.16 Million PLN | 3.82% |
2017 Q1 | 87.76 Million PLN | 0.32% |
2017 Q4 | 102.29 Million PLN | 14.73% |
2017 FY | 102.29 Million PLN | 16.94% |
2017 Q2 | 85.88 Million PLN | -2.14% |
2016 Q3 | 77.75 Million PLN | 3.67% |
2016 FY | 87.48 Million PLN | 8.78% |
2016 Q4 | 87.48 Million PLN | 12.51% |
2016 Q2 | 75 Million PLN | -2.81% |
2016 Q1 | 77.17 Million PLN | -4.05% |
2015 Q2 | 65.54 Million PLN | 3.77% |
2015 Q3 | 73.19 Million PLN | 11.68% |
2015 Q4 | 80.42 Million PLN | 9.87% |
2015 FY | 80.42 Million PLN | 33.44% |
2015 Q1 | 63.16 Million PLN | 4.8% |
2014 Q3 | 55.14 Million PLN | 0.05% |
2014 FY | 60.26 Million PLN | -4.22% |
2014 Q1 | 62.47 Million PLN | -0.71% |
2014 Q4 | 60.26 Million PLN | 9.28% |
2014 Q2 | 55.12 Million PLN | -11.78% |
2013 Q4 | 62.92 Million PLN | -6.06% |
2013 FY | 62.92 Million PLN | -15.67% |
2013 Q2 | 72.06 Million PLN | -3.88% |
2013 Q3 | 66.98 Million PLN | -7.05% |
2013 Q1 | 74.97 Million PLN | 0.48% |
2012 FY | 74.61 Million PLN | 13.67% |
2012 Q1 | 66.03 Million PLN | 0.58% |
2012 Q2 | 72.47 Million PLN | 9.76% |
2012 Q4 | 74.61 Million PLN | -0.5% |
2012 Q3 | 74.99 Million PLN | 3.47% |
2011 Q4 | 65.64 Million PLN | 35.73% |
2011 FY | 65.64 Million PLN | 16.62% |
2011 Q3 | 48.36 Million PLN | -2.55% |
2011 Q2 | 49.63 Million PLN | 0.0% |
2010 Q4 | 56.29 Million PLN | 0.0% |
2010 FY | 56.29 Million PLN | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
EMC Instytut Medyczny SA | 248.35 Million PLN | -27.109% |